| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |